IN · d2c · health · nutrition
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series B · Jun 2026 · $30M
OrbiMed lead
Reported by Inc42
Missing a round, or an investor who was in one? Tell us.